Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Aurinia Pharmaceuticals Inc Share Holder Equity 2014-2025 | AUPH

Aurinia Pharmaceuticals Inc share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  
Aurinia Pharmaceuticals Inc Annual Share Holder Equity
(Millions of US $)
2024 $377
2023 $378
2022 $405
2021 $479
2020 $408
2019 $299
2018 $113
2017 $166
2016 $36
2015 $20
2014 $34
2013 $0
Aurinia Pharmaceuticals Inc Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $350
2024-12-31 $377
2024-09-30 $388
2024-06-30 $365
2024-03-31 $359
2023-12-31 $378
2023-09-30 $392
2023-06-30 $392
2023-03-31 $390
2022-12-31 $405
2022-09-30 $423
2022-06-30 $424
2022-03-31 $448
2021-12-31 $479
2021-09-30 $298
2021-06-30 $332
2021-03-31 $370
2020-12-31 $408
2020-09-30 $399
2020-06-30 $239
2020-03-31 $263
2019-12-31 $299
2019-09-30 $124
2019-06-30 $126
2019-03-31 $139
2018-12-31 $113
2018-09-30 $125
2018-06-30 $142
2018-03-31 $152
2017-12-31 $166
2017-09-30 $168
2017-06-30 $178
2017-03-31 $173
2016-12-31 $36
2016-09-30 $20
2016-06-30 $20
2016-03-31 $16
2015-12-31 $20
2015-09-30 $24
2015-06-30 $28
2015-03-31 $28
2014-12-31 $34
2014-09-30 $49
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.225B $0.235B
Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.846B 28.83
Zoetis (ZTS) United States $66.795B 24.92
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
Daiichi Sankyo, - (DSNKY) Japan $45.540B 23.34
BeOne Medicines - (ONC) Cayman Islands $31.822B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $20.520B 0.00
Merck (MKKGY) Germany $16.743B 12.27
Shionogi (SGIOY) Japan $14.360B 14.39
United Therapeutics (UTHR) United States $13.412B 11.86
Neurocrine Biosciences (NBIX) United States $13.272B 45.46
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.752B 63.02
Madrigal Pharmaceuticals (MDGL) United States $7.743B 0.00
Stevanato Group S.p.A (STVN) Italy $7.719B 47.20
Grifols, S.A (GRFS) Spain $6.910B 0.00
Ionis Pharmaceuticals (IONS) United States $6.712B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.417B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.583B 13.97
NewAmsterdam Pharma (NAMS) Netherlands $2.468B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.132B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.820B 0.00
Ocular Therapeutix (OCUL) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.802B 0.00
Endo (NDOI) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Harrow (HROW) United States $1.326B 0.00
Guardian Pharmacy Services (GRDN) United States $1.317B 0.00
Enliven Therapeutics (ELVN) United States $1.145B 0.00
Ardelyx (ARDX) United States $1.081B 0.00
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $1.037B 5.59
ProKidney (PROK) United States $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Verve Therapeutics (VERV) United States $0.976B 0.00
Xeris Biopharma Holdings (XERS) United States $0.818B 0.00
KalVista Pharmaceuticals (KALV) United States $0.800B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.738B 0.00
Zevra Therapeutics (ZVRA) United States $0.692B 0.00
Xencor (XNCR) United States $0.646B 0.00
Relay Therapeutics (RLAY) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Theravance Biopharma (TBPH) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.570B 12.40
Organogenesis (ORGO) United States $0.553B 0.00
Bioventus (BVS) United States $0.533B 13.52
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.478B 0.00
Aquestive Therapeutics (AQST) United States $0.434B 0.00
Savara (SVRA) United States $0.404B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Altimmune (ALT) United States $0.328B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
AleAnna (ANNA) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.88
Nanobiotix S.A (NBTX) France $0.250B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Liminatus Pharma (LIMN) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 19.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Vivani Medical (VANI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Rafael Holdings (RFL) United States $0.080B 0.00
Metagenomi (MGX) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Klotho Neurosciences (KLTO) United States $0.063B 0.00
Avalo Therapeutics (AVTX) United States $0.061B 0.00
Inotiv (NOTV) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 41.22
ElectroCore (ECOR) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.45
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00